Industry insiders reviewed trade challenges, regulatory developments, emerging market opportunities, and more issues in today's dietary supplement market.
Evidence-based, non-GMO palm bioactives meeting global quality & compliance standards.
Companies that lead with science, transparency, and trust will be better positioned to redefine the future of health and nutrition.
The FDA can address longstanding uncertainty by harmonizing complex statutory provisions instead of taking shortcuts that lead to confusion.
Consumers want foundational, holistic, natural nutrition, yet still demand innovation, targeted benefits, and measurable results.
Skye Chilton, CEO of Nammex, discusses mushroom market trends, current challenges, product innovation, and the health benefits of fungi.
Founder Adam Grossman says quality assurance and trust are cornerstones of the company’s CBD brand.
